Literature DB >> 7286886

Prolactinomas and optic nerve compression: disappearance of suprasellar extension and visual recovery after two weeks bromocriptine treatment.

N J Woodhouse, F Khouqueer, J O Sieck.   

Abstract

4 patients with prolactinomas and visual field defects are presented. 2 were treated with bromocriptine alone; 1 patient with an 8-month history of visual disturbance had complete recovery of visual fields after 2 weeks and an acute fall in serum prolactin levels. This coincided with disappearance of the suprasellar extension on computer tomography (CT) scanning. The second patient, with a 2-year history, had no visual improvement after 1 year of treatment, although CT scanning showed absence of the suprasellar extension when repeated after 3 months. 2 other patients initially had neurosurgery; 1 with a 2-year history had complete visual recovery, the other with a 1-year history did not recover. Both needed subsequent bromocriptine treatment. In all 4 patients this drug produced a sustained fall in serum prolactin levels. We conclude that bromocriptine therapy can rapidly reduce prolactinoma tumor size and should obviate the necessity for acute neurosurgical intervention in carefully selected patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7286886     DOI: 10.1159/000179381

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  5 in total

1.  Combined treatment of invasive giant prolactinomas.

Authors:  Chonjiang Yu; Zhebao Wu; Jian Gong
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

2.  The 'Alice in Wonderland' experience. Ergot alkaloid therapy for prolactin-secreting pituitary tumors.

Authors:  R C Williams; C Sherman; M T Buckman
Journal:  West J Med       Date:  1983-03

3.  Bromocriptine treatment of macroprolactinomas: studies on the time course of tumor shrinkage and morphology.

Authors:  M Nissim; B Ambrosi; V Bernasconi; G Giannattasio; M A Giovanelli; M Bassetti; U Vaccari; P Moriondo; A Spada; P Travaglini; G Faglia
Journal:  J Endocrinol Invest       Date:  1982 Nov-Dec       Impact factor: 4.256

4.  Long-acting bromocriptine for the acute treatment of large macroprolactinomas.

Authors:  A Zarate; C Moran; R Miranda; M Loyo; M Medina; M E Fonseca
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

5.  Bromocriptine-induced removal of endoplasmic membranes from prolactinoma cells.

Authors:  A M Landolt; V Osterwalder; T A Landolt
Journal:  Experientia       Date:  1985-05-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.